Current Assets
Short-Term Investments
Vertex Pharmaceuticals Short-Term Investments increased by 15.1% to $1.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $1.53B to $1.75B. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows an upward trend with a 17.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 5, 2026
How to read this metric
High levels suggest strong liquidity and a conservative cash management strategy, often used to fund future R&D.
Detailed definition
These are highly liquid, marketable securities with maturities between three and twelve months. They represent the compa...
Peer comparison
Commonly high in biotech companies to ensure sufficient runway for long-term clinical trials.
Metric ID:
short_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $644.32M | $685.19M | $729.9M | $638M | $551.2M | $599.2M | $274.5M | $1.12B | $1.09B | $818M | $849.2M | $1.01B | $1.22B | $1.29B | $1.55B | $1.53B | $1.41B | $1.35B | $1.52B | $1.75B |
| QoQ Change | — | +6.3% | +6.5% | -12.6% | -13.6% | +8.7% | -54.2% | +309.5% | -3.5% | -24.6% | +3.8% | +19.3% | +19.9% | +5.8% | +20.3% | -1.3% | -7.6% | -4.5% | +13.1% | +15.1% |
| YoY Change | — | — | — | — | -14.5% | -12.5% | -62.4% | +76.2% | +96.9% | +36.5% | +209.4% | -9.9% | +12.0% | +57.1% | +82.1% | +50.6% | +16.1% | +4.8% | -1.5% | +14.9% |
Range$274.5M – $1.75B
CAGR+23.5%
Avg YoY Growth+34.7%
Median YoY Growth+15.5%
Current Streak2 quarters growth
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's short-term investments?
- Vertex Pharmaceuticals (VRTX) reported short-term investments of $1.75B in Q1 2026.
- How has Vertex Pharmaceuticals's short-term investments changed year-over-year?
- Vertex Pharmaceuticals's short-term investments increased by 14.9% year-over-year, from $1.53B to $1.75B.
- What is the long-term trend for Vertex Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's short-term investments has grown at a 17.8% compound annual growth rate (CAGR), from $670.7M to $1.52B.
- What does short-term investments mean?
- Liquid investments that can be converted to cash within one year.